Literature DB >> 6245036

Effects of a new glucocorticoid, deflazacort, on pituitary-adrenal function in man: a comparison with prednisone.

D Criscuolo, F Fraioli, V Bonifacio, D Paolucci, A Isidori.   

Abstract

The influence on plasma ACTH and cortisol and on blood sugar have been evaluated in seven volunteers after single oral doses of prednisone 4 mg and 8 mg and deflazacort 5 mg and 10 mg. Drugs were administered at midnight to achieve a maximum inhibitory effect on the hypothalamic-pituitary-adrenal axis. No difference was detected in the majority of cases between the high and the low dose of each drug. In particular, the results obtained with the higher doses show a significant effect of both drugs on ACTH (at hour 4 after drug administration) and on cortisol (at hours 4, 8, 12 and 16). As for blood sugar, the hyperglycemic activity of deflazacort appears to be lower than prednisone at hours 12 and 16. On the whole, the potency of deflazacort appears similar to that of prednisone.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245036

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  8 in total

1.  Effects of prednisone and deflazacort on vertebral bone mass.

Authors:  C Gennari; B Imbimbo
Journal:  Calcif Tissue Int       Date:  1985-12       Impact factor: 4.333

2.  Corticosteroids and bone.

Authors:  W Peck; C Gennari; L Raisz; P Meunier; E Ritz; S Krane; G Nuki; L V Avioli
Journal:  Calcif Tissue Int       Date:  1984-01       Impact factor: 4.333

3.  Assessment of the systemic effects of inhaled glucocorticosteroids: the influence of blood sampling technique and frequency on plasma cortisol and leucocytes.

Authors:  B H Jennings; K E Andersson; S A Johansson
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans.

Authors:  C Gennari; B Imbimbo; M Montagnani; M Bernini; P Nardi; L V Avioli
Journal:  Calcif Tissue Int       Date:  1984-05       Impact factor: 4.333

Review 5.  Synthesis and pharmacology of anti-inflammatory steroidal antedrugs.

Authors:  M Omar F Khan; Henry J Lee
Journal:  Chem Rev       Date:  2008-12       Impact factor: 60.622

6.  In vitro immunosuppressive potency of deflazacort, a new bone-sparing corticosteroid on T lymphocytes, NK and K cells.

Authors:  E Langhoff; K Olgaard
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

7.  Lack of effect of deflazacort, a novel glucocorticoid, on basal and TRH-stimulated prolactin and thyrotropin levels in healthy subjects.

Authors:  C Barbieri; C Baruto; M Sala; G Bigatti; M Parodi; P Bellini; M Bevilacqua
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Establishment of the relative antiinflammatory potency of deflazacort and prednisone in polymyalgia rheumatica.

Authors:  B Lund; C Egsmose; S Jørgensen; M R Krogsgaard
Journal:  Calcif Tissue Int       Date:  1987-12       Impact factor: 4.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.